Eledon Pharmaceuticals Stock Momentum Indicators Commodity Channel Index

ELDN Stock  USD 4.66  0.17  3.52%   
Eledon Pharmaceuticals momentum indicators tool provides the execution environment for running the Commodity Channel Index indicator and other technical functions against Eledon Pharmaceuticals. Eledon Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Commodity Channel Index indicator function is designed to identify and follow existing trends. Momentum indicators of Eledon Pharmaceuticals are pattern recognition functions that provide distinct formation on Eledon Pharmaceuticals potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Commodity Channel Index (CCI) is designed to detect Eledon Pharmaceuticals beginning and ending market trends using 100 to -100 scale. CCI values outside of this range indicate overbought or oversold conditions. If the price of Eledon Pharmaceuticals is making new highs, and the CCI is not, then a price correction is likely to happen soon.

Eledon Pharmaceuticals Technical Analysis Modules

Most technical analysis of Eledon Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Eledon from various momentum indicators to cycle indicators. When you analyze Eledon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Eledon Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Eledon Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eledon Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Eledon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eledon Pharmaceuticals's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Eledon Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Eledon Pharmaceuticals, we also check how macroeconomic factors affect Eledon Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2010 2023 2024 (projected)
Dividend Yield0.0011180.0010078.94E-4
Price To Sales Ratio186.27167.64149.02
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eledon Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.234.639.72
Details
Intrinsic
Valuation
LowRealHigh
2.267.3512.44
Details
Naive
Forecast
LowNextHigh
0.575.6610.75
Details
6 Analysts
Consensus
LowTargetHigh
15.0216.5018.32
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Eledon Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eledon Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eledon Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eledon Pharmaceuticals Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.73
Return On Assets
(0.33)
Return On Equity
(0.25)
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.